SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOSL1 | hg19_v2_chr11_-_65667884_65667895 | 0.94 | 6.5e-10 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_95007193 Show fit | 42.94 |
ENST00000370207.4
ENST00000334047.7 |
coagulation factor III (thromboplastin, tissue factor) |
|
chr17_-_39769005 Show fit | 39.27 |
ENST00000301653.4
ENST00000593067.1 |
keratin 16 |
|
chr3_-_151034734 Show fit | 38.53 |
ENST00000260843.4
|
G protein-coupled receptor 87 |
|
chr17_-_39743139 Show fit | 33.59 |
ENST00000167586.6
|
keratin 14 |
|
chr1_+_183155373 Show fit | 32.68 |
ENST00000493293.1
ENST00000264144.4 |
laminin, gamma 2 |
|
chr2_+_113875466 Show fit | 27.41 |
ENST00000361779.3
ENST00000259206.5 ENST00000354115.2 |
interleukin 1 receptor antagonist |
|
chr17_-_39781054 Show fit | 27.09 |
ENST00000463128.1
|
keratin 17 |
|
chr17_-_39780819 Show fit | 26.69 |
ENST00000311208.8
|
keratin 17 |
|
chr18_+_21452804 Show fit | 26.09 |
ENST00000269217.6
|
laminin, alpha 3 |
|
chr16_-_2908155 Show fit | 25.62 |
ENST00000571228.1
ENST00000161006.3 |
protease, serine, 22 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 104.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
2.8 | 98.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
2.6 | 76.6 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.8 | 57.1 | GO:0018149 | peptide cross-linking(GO:0018149) |
14.3 | 42.9 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
6.0 | 42.1 | GO:0071461 | cellular response to redox state(GO:0071461) |
5.9 | 35.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
1.5 | 33.8 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
4.1 | 32.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
3.5 | 31.8 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 114.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 69.6 | GO:0005615 | extracellular space(GO:0005615) |
5.4 | 59.7 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.3 | 44.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.4 | 43.3 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 32.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 31.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
7.5 | 30.0 | GO:0005607 | laminin-2 complex(GO:0005607) |
1.5 | 27.0 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 26.4 | GO:0005769 | early endosome(GO:0005769) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 124.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.7 | 101.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
9.8 | 78.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 52.4 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 50.6 | GO:0030674 | protein binding, bridging(GO:0030674) |
3.5 | 42.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 35.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
1.5 | 33.8 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 28.9 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 27.6 | GO:0003779 | actin binding(GO:0003779) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 136.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
3.6 | 101.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.9 | 66.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 43.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 39.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 22.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 21.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 20.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 17.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 16.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 116.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 52.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.9 | 42.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 25.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 24.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.6 | 18.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.5 | 14.6 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.6 | 14.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.6 | 13.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.5 | 13.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |